Wird geladen...

Immunomodulatory Drugs in the Management of SARS-CoV-2

With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain disease-modifying drugs that are used for the management of inflammatory disorders such as rheumatoid arthritis, spondyloarthrosis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Daniel R. Burrage, Soraya Koushesh, Nidhi Sofat
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2020-08-01
Schriftenreihe:Frontiers in Immunology
Schlagworte:
Online Zugang:https://www.frontiersin.org/article/10.3389/fimmu.2020.01844/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!